Newsletter Archives

Showing 281 to 300 of 876 articles.

EBM Focus - Volume 15, Issue 23

Does consuming organic foods really reduce your cancer risk?

EBM Focus - Volume 15, Issue 22

Black patients may be at increased risk of COVID-19 hospitalization and death

MBE em foco - Volume 6, Issue 9

Enfiando a agulha: tPA para AVC ao despertar, ou administrado mais de 4,5 horas após o início dos sintomas, pode melhorar a funcionalidade a 90 dias

EBM Focus - Volume 15, Issue 21

Workplace wellness programs appear to have little effect on health outcomes of benefits-eligible employees

EBM Focus - Volume 15, Issue 20

Early data promising: Remdesivir for COVID-19 may speed time to recovery but mortality benefit is uncertain

EBM Focus - Volume 15, Issue 19

Hold the knife - are antibiotics a reasonable option for pediatric appendicitis?

MBE em foco - Volume 6, Issue 8

Opiniões de especialistas e evidências de baixa qualidade ainda direcionam a maioria das recomendações fortes em cardiologia

EBM Focus - Volume 15, Issue 18

Convalescent plasma therapy for COVID-19: Hope or hype?

MBE em foco - Volume 6, Issue 7

Não são os inibidores da ECA que estão matando as pessoas com COVID-19

EBM Focus - Volume 15, Issue 17

Surrogate markers in pregnancy: should we adopt new guidance suggesting cesarean delivery for HSV in the third trimester?

EBM Focus - Volume 15, Issue 16

It’s not the ACE inhibitors that are killing people with COVID-19

MBE em foco - Volume 6, Issue 6

Canagliflozina para proteção renal: não é um novo inibidor da ECA

EBM Focus - Volume 15, Issue 15

CPAP doesn’t improve outcomes in patients with ACS and OSA, especially if they don’t use it

MBE em foco - Volume 6, Issue 5

Uma perspectiva da MBE sobre a hidroxicloroquina e a azitromicina para o tratamento da COVID-19

EBM Focus - Volume 15, Issue 14

Injecting evidence into management of knee OA

EBM Focus - Volume 15, Issue 13

A new tool to help identify true penicillin allergies

MBE em foco - Volume 6 Issue 4

Quarenta a cinquenta tons de cinza: orientações do ACP destacam os danos da mamografia de rastreamento em mulheres de risco médio com idades entre 40 e 50 anos

EBM Focus - Volume 15, Issue 12

An EBM perspective on hydroxychloroquine and azithromycin for the treatment of COVID-19

EBM Focus - Volume 15, Issue 11

COVID-19: 10 things you need to know

EBM Focus - Volume 15, Issue 10

Lose the lozenge: zinc stinks for treating URIs